Operating Expenses: The sum of all operating expenses for the given industry.
Arrowhead Pharmaceuticals, Inc. (ARWR) had Operating Expenses of $215.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$73.74M |
|
$-132.73M |
|
-- |
|
$73.74M |
|
|
Operating Expenses |
$215.00M |
$-141.26M |
|
$3.69M |
|
$-137.56M |
|
$-130.85M |
|
$-137.57M |
|
$-137.57M |
|
$-137.57M |
|
$-130.85M |
|
$-141.26M |
|
$-136.75M |
|
142.42M |
|
142.42M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$1.84B |
|
$374.82M |
|
$428.51M |
|
$2.27B |
|
$295.22M |
|
$841.58M |
|
$1.37B |
|
$1.67B |
|
$598.92M |
|
$592.90M |
|
$598.92M |
|
140.57M |
|
| Cash Flow Statement Financials | |
$97.92M |
|
$-918.02M |
|
$780.97M |
|
$226.55M |
|
$188.52M |
|
$-38.03M |
|
$36.04M |
|
$-41.51M |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.23 |
|
-- |
|
-- |
|
0.58 |
|
1.47 |
|
100.00% |
|
-191.57% |
|
-191.57% |
|
-- |
|
-186.56% |
|
-180.01% |
|
$93.21M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
4.70 |
|
19.14 |
|
-22.97% |
|
-23.20% |
|
-6.07% |
|
-9.55% |
|
$4.26 |
|
$0.65 |
|
$0.69 |
|